ArticleHuman vaccines & immunotherapeutics2013

Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8+ T cell responses against a HBV DNA vaccine in mice.

Bing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.